Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Eurofins for Biomnis?

Biomnis, one of the two large French reference labs, could be bought by Eurofins, which claims to be the world leader in food and environmental lab services. Eurofins, which is quoted, is one of two remaining bidders, according to a French news report.

Cinven scoops Labco (revised story)

Private equity house Cinven is to buy Labco for an enterprise value of just €1.2bn. The news came two weeks after Labco’s IPO failed. We reflect here on the EBITDA multiple and at what this means for the rationalisation of the European market. Who will Cinven buy next?

Report: Europe’s booming spa business stays out of hot water

The spa industry is changing. Once exclusively for the wealthy, spas are becoming more accessible and more in demand. Remote luxury locations where people can escape to relax and take in the healing powers of massage and natural baths is still the favoured model. But, there is a push throughout Europe to bring the spa experience closer to home. A new trend of urban spas or locations within 20- 40 mile of cities is just one of the trends. Payors across Europe are starting to gain interest, but to what extent? Healthcare Europa’s Lee Murray takes a look at this expanding $29.8bn (€27.1bn) market, according to figures from research group SRI International.

FREE BLOG In search of the new spa…

The word spa conjures up a Mittel Europa image of a luxury hotel full of wrinklies taking the water. As our feature shows, this now far from the truth.

Report: The future of tech in healthcare

A cross between an Apple keynote and a TED Talk, the Health 2.0 Europe conference in Barcelona brought a touch of California to the old continent and was an opportunity to look at the latest range of healthcare apps. We report on the weird and wacky.

Spanish election creates uncertainty

Sunday’s regional and municipal elections have shaken up Spain’s political landscape. Left-wing parties have increased their vote causing concern for private healthcare operators. Ribera Salud, a hospital group with large public concessions, probably faces a coalition led by the Socialists in its Valencia heartland.

The €20 MRI is close to reality

Whilst the tariff for an MRI in Western Europe can be as high as €300 a shot, it is now sub-€100 in Eastern Europe. But in Turkey the target price is €20, says Dimitris Moulavasilis, CEO of Affidea.

Cinven scoops Labco at silly price

Private equity house Cinven is to buy Labco for an enterprise value of just €1.2bn. The news came two weeks after Labco’s IPO failed. We reflect here on the EBITDA multiple and at what this means for the rationalisation of the European market.

Find Us